Skip to main content

Table 1 The characteristics of the selected patients

From: Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes

  NSLN negative NSLN positive
Patient ID 84816 94948 67161 76948 86923 94812
Tumor type IDC IDC IDC IDC IDC IDC
Tumor grade MD MD MD MD MD MD
Tumor size (cm) 1.5 1 3 3 2 2.5
SLN (P/T) 1/2 1/4 1/1 2/2 1/1 1/2
ALN (P/T) 0/18 0/16 0/18 1/21 2/21 1/28
ER 3+, >75 % 3+, >75 % 2+, 50–70 % 2+, 50–75 % 3+, >75 % 3+, >75 %
PR 3+, >75 % 1+, ~15 % 1+, 10–30 % 1+, 25–50 % 2+, 50–60 % 3+, >75 %
HER2 Negative Negative Negative Negative Negative Negative
Ki-67 3–5 % 20 % 15–20 % 10 % 10 % 5–10 %
  1. IDC invasive ductal carcinoma, MD moderate differentiated, P positive, T total